| Leatha B Hayes, DO | |
|
303 Timber Ridge Drive, Ridgeland, MS 39157 | |
| (601) 832-0520 | |
| (601) 898-2379 |
| Full Name | Leatha B Hayes |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 303 Timber Ridge Drive, Ridgeland, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952556904 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 5101008597 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Leatha B Hayes, DO 303 Timber Ridge Drive, Ridgeland, MS 39157 Ph: (601) 832-0520 | Leatha B Hayes, DO 303 Timber Ridge Drive, Ridgeland, MS 39157 Ph: (601) 832-0520 |
News Archive
Since 2006, research has succeeded in generating, from specialised adult cells, induced pluripotent cells (iPS cells), with huge potential applications, particularly for regenerative medicine. However, the process has still not been completely mastered. Two teams of researchers from Inserm, CNRS, Centre Léon Bérard and Claude Bernard Lyon 1 University have discovered a molecule that may favour the production of these induced stem cells.
Hossein Tavana, Ph.D., an associate professor of biomedical engineering at The University of Akron (UA), has received a single-PI grant in the amount of $328,426 from the National Science Foundation - his third federal grant this year - to study the role of stromal cells in cancer.
Armetheon, Inc., a clinical stage biopharmaceutical company, announced today that it plans to develop its novel oral anti-coagulant (OAC), tecarfarin (ATI-5923), for a patient population which includes those who have prosthetic heart valves or chronic renal dysfunction.
The new synthetic drug nicknamed Oz is set to become the major weapon in the fight against multi-drug resistant malaria and could be available to patients within three years.
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that its compound CM-182 demonstrated positive results for schizophrenia in the transgenic chakragati (ckr) model of psychosis. The mouse model screening was performed by the Contract Research Organization, Cerca Insights.
› Verified 2 days ago
Michael L Sanders, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 201 Highway 51 Unit A, Ridgeland, MS 39157 Phone: 601-790-7105 Fax: 601-790-7865 | |
Richard Price, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 230 Trace Colony Ste 2, Ridgeland, MS 39157 Phone: 601-992-3996 Fax: 769-300-3112 | |
Timothy Michael Quinn, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 768 Avery Blvd N, Ridgeland, MS 39157 Phone: 601-487-6482 Fax: 601-487-6528 | |
Dr. Robert L Russell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 Highway 51, Ridgeland, MS 39157 Phone: 601-856-9980 Fax: 601-856-9994 | |
Mrs. Sabrita Recheal Hopkins, NP-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 133 Rivergate Cv, Ridgeland, MS 39157 Phone: 601-201-7522 | |
Kristi Kay Trimm, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1051 Highland Colony Pkwy Ste E, Ridgeland, MS 39157 Phone: 601-707-3737 | |
Rommel Asagwara, M.D., Family Medicine Medicare: Medicare Enrolled Practice Location: 1060 E County Line Rd Ste 1a, Ridgeland, MS 39157 Phone: 769-444-5673 |